Private Equity Portfolio Company
Atox Bio
Ness Ziona
Israel
https://www.atoxbio.com
Atox Bio is a late stage biotechnology company that develops novel immunomodulators to treat critically ill patients with an initial focus on developing immunomodulators for necrotizing soft tissue infections....
Private Equity Owner: OrbiMed Advisors
Executives
Acquisition Criteria
Investment Date:
Exit Date:
Status:
Add-on Acquisitions:
Industry (NAICS Code):
Testimonials
Become the next customer to share a success story about Private Equity Info's impact.
"Private Equity Info is critical to nearly every aspect of our role as an investment bank. We use it almost every day and the return on investment is clear."
Bob McCormack
"PEI is superior for our sales team. It cuts to the core. It’s the sweet spot in terms of what you’re paying and what you’re getting.”
